{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:49:24Z","timestamp":1761058164641},"reference-count":36,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2004,12,2]],"date-time":"2004-12-02T00:00:00Z","timestamp":1101945600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:p><jats:bold>BACKGROUND:\u2002<\/jats:bold> The emergence of variant Creutzfeldt\u2010Jakob disease (vCJD) and of a probable transmission of the disease through blood transfusion from a presymptomatic case has underlined the need for a reliable, sensitive, and specific screening test. This study was initiated to explain why attempts to identify protease\u2010resistant prion protein (PrPres) following treatment with proteinase K (PK) in blood or blood components have so far failed.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:\u2002<\/jats:bold> RIII mice were inoculated intracerebrally (i.c.) with vCJD agent. As soon as some mice became ill, blood from all mice was collected, pooled, and separated into components. Aliquots of plasma were treated with either 100 and 500\u2003\u00b5g per mL PK or left untreated. Samples were analyzed for total protein and for PrPres by Western blot with 6H4 antibodies. Infectivity in PK\u2010treated and untreated samples was bioassayed by i.c. inoculation into healthy mice.<\/jats:p><jats:p><jats:bold>RESULTS:\u2002<\/jats:bold> Estimated infectivity in untreated control plasma was 20.6\u2003IU per mL. Treatment of plasma with 100 or 500\u2003\u00b5g per mL PK resulted in estimated infectivity levels of 8.4 and 5.2\u2003IU per mL, respectively. Coomassie staining revealed substantial changes in the protein profile after PK treatment, with massive degradation of proteins at 500\u2003\u00b5g per mL PK. No PrPres was detected in plasma samples by Western blotting.<\/jats:p><jats:p><jats:bold>CONCLUSION:\u2002<\/jats:bold> Infectivity in plasma of vCJD\u2010infected mice showed a trend toward reduction following enzymatic treatment with increasing doses of PK, possibly because of activity against proteolysis\u2010sensitive isoforms of abnormal prion protein. It is concluded that the use of PK in protocols for the detection of PrPres may decrease the sensitivity of blood\u2010based assays.<\/jats:p>","DOI":"10.1111\/j.0041-1132.2004.04198.x","type":"journal-article","created":{"date-parts":[[2004,12,2]],"date-time":"2004-12-02T11:45:23Z","timestamp":1101987923000},"page":"1700-1705","source":"Crossref","is-referenced-by-count":23,"title":["Effect of protease treatment on plasma infectivity in variant Creutzfeldt\u2010Jakob disease mice"],"prefix":"10.1111","volume":"44","author":[{"given":"Oksana","family":"Yakovleva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Janiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carroll","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"McShane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Cervenakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,12,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91412-9"},{"key":"e_1_2_6_3_2","volume-title":"Monthly Creutzfeldt\u2010Jakob disease statistics (Internet).","author":"Department of Health.","year":"2004"},{"key":"e_1_2_6_4_2","volume-title":"The European and Allied Countries Collaborative Study Group of CJD (Euro CJD)."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12632-3"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1580"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15486-X"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16811-6"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1998.38998408999.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1999.39111169.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0041-1132.2003.00586.x"},{"key":"e_1_2_6_12_2","volume-title":"Titer, distribution, and transmissibility of blood\u2010borne TSE infectivity.","author":"Rohwer RG","year":"2000"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02719-7"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-11-2897"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1067\/mlc.2001.111951"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1988.tb14246.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/elps.200390107"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.2307\/3001707"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.2307\/2532255"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.1999.7720088.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02158.x"},{"key":"e_1_2_6_22_2","first-page":"268","article-title":"Expression of cellular prion protein on blood cells: potential functions in cell physiology and pathophysiology of transmissible spongiform encephalopathy diseases","volume":"15","author":"Vostal JG","year":"2001","journal-title":"Transfus Med Rev"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3886(00)00010-2"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41040441.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00072.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2001.41111453.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.142.21.564"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.9.3254-3259.2000"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)24002-X"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)24035-9"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12075-5"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.012278"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030351"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhin.2000.0790"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm883"},{"key":"e_1_2_6_36_2","volume-title":"Use of the Seprion ligand system in ante\u2010mortem testing for TSEs.","author":"Wilson S","year":"2004"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.4.2088-2099.2004"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0041-1132.2004.04198.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0041-1132.2004.04198.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0041-1132.2004.04198.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T08:53:56Z","timestamp":1697273636000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0041-1132.2004.04198.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1111\/j.0041-1132.2004.04198.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0041-1132.2004.04198.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}